SCHEMBL8249762

SCHEMBL8249762

CCC[C@H](NC(=O)[C@H](CSC(C)=O)Cc1ccccc1)C(=O)OC

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 2/20 0.56
CYP2C19 P33261 2/20 0.56
CYP1A2 P05177 1/20 0.56
CYP3A4 P08684 1/20 0.56
CYP2D6 P10635 1/20 0.56
ABCC3 O15438 1/20 0.56
NR1I2 O75469 1/20 0.56
ABCB11 O95342 1/20 0.56
NR3C1 P04150 1/20 0.56
RARG P13631 1/20 0.56
CNR1 P21554 1/20 0.56
OPRK1 P41145 1/20 0.56
NR1H2 P55055 1/20 0.56
PPARA Q07869 1/20 0.56
NR1H3 Q13133 1/20 0.56
NR1I3 Q14994 1/20 0.56
BIRC2 Q13490 2/20 0.53
HDAC3 O15379 2/20 0.52
HDAC4 P56524 2/20 0.52
HDAC1 Q13547 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8165462 0.91 CYP2C9 (0.61) CYP2C9CYP2C19CYP1A2CYP3A4CYP2D6
SCHEMBL11245255 0.90 CYP1A2 (0.53) CYP2C9CYP2C19CYP1A2CYP3A4CYP2D6
SCHEMBL11258506 0.90 CYP1A2 (0.53) CYP2C9CYP2C19CYP1A2CYP3A4CYP2D6
SCHEMBL7328108 0.89 MME (0.59) CYP2C9CYP2C19CYP1A2CYP3A4CYP2D6
SCHEMBL7328105 0.89 MME (0.59) CYP2C9CYP2C19CYP1A2CYP3A4CYP2D6
SCHEMBL7328102 0.89 MME (0.59) CYP2C9CYP2C19CYP1A2CYP3A4CYP2D6
SCHEMBL5916371 0.87 CYP2C9 (0.57) CYP2C9CYP2C19CYP1A2CYP3A4CYP2D6
SCHEMBL8249764 0.86 BIRC2 (0.67) CYP2C9CYP2C19CYP1A2CYP3A4CYP2D6
SCHEMBL5870418 0.86 BIRC2 (0.67) CYP2C9CYP2C19CYP1A2CYP3A4CYP2D6
SCHEMBL5870422 0.86 BIRC2 (0.67) CYP2C9CYP2C19CYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040082496-A1 ACE-2 modulating compounds and methods of use thereof MILLENNIUM PHARMACEUTICALS, INC. 2004-04-29 US disclosed
US-20040082496-A1 ACE-2 modulating compounds and methods of use thereof MILLENNIUM PHARMACEUTICALS, INC. 2004-04-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040082496-A1 ACE-2 modulating compounds and methods of use thereof ACE, ACE2, AGTR2 CYP2C9 1997/4885CYP2C19 1489/4885CYP1A2 827/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.